Diabetic Macular Edema Clinical Trials Database - Free Access to 301 Studies
Access comprehensive clinical trial information for Diabetic Macular Edema through Pure Global AI's free database. This collection includes 301 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 42 trials are actively recruiting participants.
Research for Diabetic Macular Edema is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Jaeb Center for Health Research. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema
Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
Describing Patient With DME, Their Patient Journey and Disease Progression
Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
Gene Therapy for Diabetic Macular Edema
Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema
A Study of ASKG712 in Patients With Diabetic Macular Edema
Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:
Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
Evaluation of Tonabersat for DME
IVI Aflibercept Before and After Phaco in DME.
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
Comparison of Treatments in Diabetic Macular Edema
Pure Global AI provides free access to 301 clinical trials studying Diabetic Macular Edema, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Jaeb Center for Health Research, Shahid Beheshti University of Medical Sciences, among others.